Ayd\u0131n\u2019da yakla\u015f\u0131k \u00e7eyrek as\u0131r \u00f6nce do\u011fal \u00fcr\u00fcnlerden haz\u0131rlad\u0131\u011f\u0131 ve t\u0131p camias\u0131 taraf\u0131ndan da kabul g\u00f6ren \u2018Antikoil HBX-2371\u2019 adl\u0131 bir \u00fcr\u00fcn geli\u015ftiren Adnan Menderes \u00dcniversitesi (AD\u00dc) Teknokent b\u00fcnyesinde faaliyet g\u00f6steren Karya Farma HBX Ar-Ge Kurucusu Hakan Ba\u015fl\u0131k, gizemli \u00e7al\u0131\u015fmalar\u0131n\u0131n temelinde kar\u0131ncalar ve bal ar\u0131lar\u0131 oldu\u011funu a\u00e7\u0131klad\u0131. \u015eu anda 18 patente sahip olan \u00fcr\u00fcn\u00fcn\u00fc t\u00fcm a\u015famalar\u0131nda kar\u0131nca ve balar\u0131lar\u0131n\u0131n test etti\u011fini belirten Ba\u015fl\u0131k, “Kar\u0131nca ve balar\u0131lar\u0131 zararl\u0131 \u00fcr\u00fcne gelmiyor” diyerek, ba\u015far\u0131ya bu gizemli canl\u0131lar\u0131n testiyle ula\u015ft\u0131\u011f\u0131n\u0131 ifade etti.
\n
Yakla\u015f\u0131k 25 y\u0131l \u00f6nce ba\u015fta Ayd\u0131n olmak \u00fczere Ege\u2019nin endemik bitkileriyle ba\u015flad\u0131\u011f\u0131 ve \u015fu anda AD\u00dc Teknokent\u2019te 18 patent ile devam eden \u00e7al\u0131\u015fmalar\u0131 hakk\u0131nda bilgi veren Hakan Ba\u015fl\u0131k, “Kainat\u0131n en gizemli ve s\u0131r dolu ya\u015fama sahip canl\u0131lar\u0131ndan biri yerdeki kar\u0131nca, di\u011feri ise az \u00fcstte u\u00e7an ar\u0131d\u0131r. Balar\u0131s\u0131 da kar\u0131nca da do\u011fal hayat\u0131n tatbik\u00e7isidir. Bu yola \u00e7\u0131karken ba\u015fta kekik, zeytin ve incir a\u011fac\u0131 ile bu iki a\u011fac\u0131n meyvelerini inceledik. Balar\u0131s\u0131 bala, kar\u0131nca ise ya\u011fa \u00fc\u015ferse o \u00fcr\u00fcn\u00fcn makbul oldu\u011funu g\u00f6rd\u00fck. Kanser hastalar\u0131 i\u00e7in endemik bitkilerden haz\u0131rlad\u0131\u011f\u0131m\u0131z kar\u0131\u015f\u0131mlar\u0131, laboratuvar ortam\u0131na g\u00f6ndermeden \u00f6nce ar\u0131lar\u0131n ve kar\u0131ncalar\u0131n testine sunduk. \u00d6nce bu canl\u0131lar\u0131n olumlu onay\u0131n\u0131 ald\u0131ktan sonra laboratuvara y\u00f6neldik ve hep olumlu sonu\u00e7lar ald\u0131k. \u015eimdi alternatif bir antibiyotik \u00fczerinde \u00e7al\u0131\u015f\u0131yoruz” dedi.
\n
\u00dczerinde \u00e7eyrek as\u0131rd\u0131r \u00e7al\u0131\u015f\u0131lan HBX-2371 form\u00fclasyonunun, antibiyotik direncine kar\u015f\u0131 yeni nesil bir biyoteknolojik \u00e7\u00f6z\u00fcm sundu\u011funu kaydeden “Ba\u015fl\u0131k, Bu form\u00fclasyon, antibiyotik direncinin yan\u0131 s\u0131ra, kanser ve n\u00f6rodejeneratif hastal\u0131klar gibi geni\u015f spektrumlu sa\u011fl\u0131k problemlerine kar\u015f\u0131 etkili olabilece\u011fi g\u00f6sterilen \u00f6zelliklere sahip. Antimikrobiyal etkisinin yan\u0131 s\u0131ra ba\u011f\u0131\u015f\u0131kl\u0131k sistemini mod\u00fcle etme, h\u00fccresel onar\u0131m mekanizmalar\u0131n\u0131 aktive etme ve sinir h\u00fccrelerini destekleme gibi \u00f6zellikler ta\u015f\u0131yor. Antibiyotikler modern t\u0131bb\u0131n temel ta\u015flar\u0131ndan biri olsa da, antibiyotik direnci d\u00fcnya \u00e7ap\u0131nda b\u00fcy\u00fck bir sa\u011fl\u0131k krizine d\u00f6n\u00fc\u015fm\u00fc\u015f durumda. Mevcut antibiyotiklerin b\u00fcy\u00fck bir k\u0131sm\u0131, bakterilerin h\u0131zl\u0131 adaptasyon s\u00fcrecine ayak uyduramad\u0131\u011f\u0131 i\u00e7in etkisiz hale geliyor. Bu noktada HBX-2371 form\u00fclasyonu yeni nesil bir \u00e7\u00f6z\u00fcm olarak \u00f6ne \u00e7\u0131k\u0131yor. Bu durum \u00f6nce kar\u0131nca ve ar\u0131lar\u0131n testi ile, sonra da laboratuvar ortam\u0131nda do\u011fruland\u0131” ifadelerini kulland\u0131.
\n
Karya Farma HBX Ar-Ge ekibinden Kimyager Asl\u0131 Akta\u015f\u2019tan a\u00e7\u0131klama
\n
AD\u00dc Teknokent b\u00fcnyesinde faaliyet g\u00f6steren Karya Farma HBX Ar-Ge ekibinden Kimyager Asl\u0131 Akta\u015f, y\u00fcr\u00fct\u00fclen bilimsel \u00e7al\u0131\u015fmalarla ilgili \u015fu a\u00e7\u0131klamada bulundu: “HBX-2371 form\u00fclasyonu, do\u011fan\u0131n kendi dengesi i\u00e7inde geli\u015ftirdi\u011fi en g\u00fc\u00e7l\u00fc biyolojik mekanizmalardan esinlenerek olu\u015fturulmu\u015ftur. Antimikrobiyal \u00f6zelliklerinin yan\u0131 s\u0131ra, kanser ve n\u00f6rodejeneratif hastal\u0131klar \u00fczerindeki etkileri, bilimsel \u00e7al\u0131\u015fmalarla da desteklenmektedir. Kar\u0131nca ve ar\u0131lar, do\u011fada sa\u011fl\u0131kl\u0131 olan\u0131 ay\u0131rt edebilen canl\u0131lard\u0131r. Bu y\u00fczden form\u00fclasyonlar\u0131m\u0131z\u0131n do\u011fall\u0131\u011f\u0131n\u0131 ve etkinli\u011fini \u00f6nce bu m\u00fckemmel biyolojik test sistemleriyle do\u011frulad\u0131k. Bilim ve do\u011fan\u0131n uyumu sayesinde, gelecekte sa\u011fl\u0131k alan\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7acak \u00e7al\u0131\u015fmalar yapmaya devam edece\u011fiz.”
<\/p>\n","protected":false},"excerpt":{"rendered":"
Ayd\u0131n\u2019da yakla\u015f\u0131k \u00e7eyrek as\u0131r \u00f6nce do\u011fal \u00fcr\u00fcnlerden haz\u0131rlad\u0131\u011f\u0131 ve t\u0131p camias\u0131 taraf\u0131ndan da kabul g\u00f6ren \u2018Antikoil HBX-2371\u2019 adl\u0131 bir \u00fcr\u00fcn geli\u015ftiren Adnan Menderes \u00dcniversitesi (AD\u00dc) Teknokent b\u00fcnyesinde faaliyet g\u00f6steren Karya Farma HBX Ar-Ge Kurucusu Hakan Ba\u015fl\u0131k, gizemli \u00e7al\u0131\u015fmalar\u0131n\u0131n temelinde kar\u0131ncalar ve bal ar\u0131lar\u0131 oldu\u011funu a\u00e7\u0131klad\u0131. \u015eu anda 18 patente sahip olan \u00fcr\u00fcn\u00fcn\u00fc t\u00fcm a\u015famalar\u0131nda kar\u0131nca…<\/p>\n","protected":false},"author":1,"featured_media":23502,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[124],"tags":[],"class_list":["post-23501","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bilim"],"_links":{"self":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/23501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23501"}],"version-history":[{"count":1,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/23501\/revisions"}],"predecessor-version":[{"id":23503,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/23501\/revisions\/23503"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/media\/23502"}],"wp:attachment":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}